Published in J Virol on June 01, 2002
Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C. J Virol (2004) 1.14
Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus. J Virol (2002) 0.91
Dynamics of viral and proviral loads of feline immunodeficiency virus within the feline central nervous system during the acute phase following intravenous infection. J Virol (2003) 0.89
A single site for N-linked glycosylation in the envelope glycoprotein of feline immunodeficiency virus modulates the virus-receptor interaction. Retrovirology (2008) 0.87
Modulation of the virus-receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivo escape from neutralising antibody. Retrovirology (2010) 0.83
The molecular biology of feline immunodeficiency virus (FIV). Viruses (2011) 0.83
Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom. Vet Microbiol (2011) 0.82
Feline immunodeficiency virus (FIV) neutralization: a review. Viruses (2011) 0.80
The virus-receptor interaction in the replication of feline immunodeficiency virus (FIV). Curr Opin Virol (2013) 0.80
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env. J Virol (2005) 0.80
Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies. PLoS One (2013) 0.78
Role of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus. J Virol (2007) 0.78
Accessory genes confer a high replication rate to virulent feline immunodeficiency virus. J Virol (2013) 0.77
Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats. Clin Diagn Lab Immunol (2003) 0.75
Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production. Virology (2010) 0.75
Real time quantitative PCR. Genome Res (1996) 35.79
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science (1987) 6.56
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell (1996) 6.52
Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 4.57
Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J Virol (1990) 2.40
Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification. Electrophoresis (1999) 2.09
Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J Virol (1997) 2.08
Molecular cloning of feline immunodeficiency virus. Proc Natl Acad Sci U S A (1989) 1.92
Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol (1991) 1.83
Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus. AIDS (1990) 1.72
Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch Virol (1989) 1.59
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J Virol (1997) 1.55
Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol (2001) 1.54
Common mechanism of infection by lentiviruses. Nature (1997) 1.47
Prevalence of feline leukaemia virus and antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec (1989) 1.43
Experimental vaccine protection against feline immunodeficiency virus. AIDS Res Hum Retroviruses (1991) 1.42
Productive infection of T-helper lymphocytes with feline immunodeficiency virus is accompanied by reduced expression of CD4. AIDS (1991) 1.33
A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells. J Virol (1995) 1.28
Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus. J Virol (1999) 1.20
The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus. J Virol (1998) 1.19
Infection with feline immunodeficiency virus is followed by the rapid expansion of a CD8+ lymphocyte subset. Immunology (1993) 1.17
A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J Virol (1993) 1.16
Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR. Gene Ther (2000) 1.14
Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol (1995) 1.11
Modulation of feline immunodeficiency virus infection by stromal cell-derived factor. J Virol (1998) 1.11
Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J Acquir Immune Defic Syndr (2001) 1.07
Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J Virol (1996) 1.03
Enhancement after feline immunodeficiency virus vaccination. Vet Immunol Immunopathol (1992) 1.03
A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism. Vet Immunol Immunopathol (1995) 1.03
Analysis of the genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus indicates a high prevalence and heterogeneity of subtype B. J Gen Virol (1997) 1.02
DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol (1998) 1.01
Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication. J Virol (1999) 1.01
A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism. J Virol (1997) 0.99
Differential cell tropism of feline immunodeficiency virus molecular clones in vivo. J Virol (1999) 0.97
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. J Virol (2000) 0.95
Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats. J Virol (1996) 0.95
The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus. Mol Membr Biol (1999) 0.95
Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. J Virol (1995) 0.94
Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in the V4 region of the surface glycoprotein. AIDS Res Hum Retroviruses (1996) 0.92
Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats. J Virol (2000) 0.91
Expansion of CD8alpha+beta- cells in cats infected with feline immunodeficiency virus. J Gen Virol (1998) 0.83
Characterization of anti-feline CD8 monoclonal antibodies. Vet Immunol Immunopathol (1998) 0.78
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J Infect Dis (2013) 4.92
The RUNX genes: gain or loss of function in cancer. Nat Rev Cancer (2005) 3.59
Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med (2009) 2.73
History of One Health and One Medicine. Vet Rec (2014) 2.61
Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science (2004) 1.93
The Runx genes: lineage-specific oncogenes and tumor suppressors. Oncogene (2004) 1.86
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog (2010) 1.65
Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. Cancer Res (2006) 1.46
Mutational analysis of conserved amino acids in the influenza A virus nucleoprotein. J Virol (2009) 1.40
Nomenclature for Runt-related (RUNX) proteins. Oncogene (2004) 1.34
The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog (2010) 1.33
Junctional adhesion molecule 1 is a functional receptor for feline calicivirus. J Virol (2006) 1.24
Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas. Cancer Res (2007) 1.12
RUNX1 transformation of primary embryonic fibroblasts is revealed in the absence of p53. Oncogene (2004) 1.12
Proviral insertion indicates a dominant oncogenic role for Runx1/AML-1 in T-cell lymphoma. Cancer Res (2002) 1.10
Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat. J Virol (2009) 1.08
Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Res (2007) 1.07
The common retroviral insertion locus Dsi1 maps 30 kilobases upstream of the P1 promoter of the murine Runx3/Cbfa3/Aml2 gene. J Virol (2002) 1.04
Feline tetherin efficiently restricts release of feline immunodeficiency virus but not spreading of infection. J Virol (2011) 1.04
Complete nucleotide sequence, genome organization and phylogenic analysis of the canine calicivirus. Virus Genes (2002) 1.04
Enforced expression of Runx2 perturbs T cell development at a stage coincident with beta-selection. J Immunol (2002) 1.03
Runx1 promotes B-cell survival and lymphoma development. Blood Cells Mol Dis (2009) 1.00
Enhanced growth of influenza vaccine seed viruses in vero cells mediated by broadening the optimal pH range for virus membrane fusion. J Virol (2011) 1.00
Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells. J Virol (2008) 0.99
Different potential of C-type lectin-mediated entry between Marburg virus strains. J Virol (2010) 0.98
An outbreak of canine distemper virus in tigers (Panthera tigris): possible transmission from wild animals to zoo animals. J Vet Med Sci (2011) 0.96
The Runx genes as dominant oncogenes. Blood Cells Mol Dis (2003) 0.94
A novel model of SCID-X1 reconstitution reveals predisposition to retrovirus-induced lymphoma but no evidence of gammaC gene oncogenicity. Mol Ther (2009) 0.93
Runx regulation of sphingolipid metabolism and survival signaling. Cancer Res (2010) 0.93
Oncogene-induced senescence: an essential role for Runx. Cell Cycle (2008) 0.92
Neuropathology associated with feline immunodeficiency virus infection highlights prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. J Neurovirol (2005) 0.92
Identification of a feline leukemia virus variant that can use THTR1, FLVCR1, and FLVCR2 for infection. J Virol (2009) 0.91
Transcriptional profiling of the host cell response to feline immunodeficiency virus infection. Virol J (2014) 0.90
A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics (2009) 0.90
Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain. Gene (2004) 0.90
RuvB-like protein 2 is a suppressor of influenza A virus polymerases. J Virol (2009) 0.90
Genetic variability of PRRS virus in Austria: consequences for molecular diagnostics and viral quantification. Vet Microbiol (2005) 0.88
Phylogenetic analysis of feline immunodeficiency virus in Central Europe: a prerequisite for vaccination and molecular diagnostics. J Gen Virol (2003) 0.88
Linkage on chromosome 10 of several murine retroviral integration loci associated with leukaemia. J Gen Virol (2002) 0.88
Longitudinal analysis of feline leukemia virus-specific cytotoxic T lymphocytes: correlation with recovery from infection. J Virol (2002) 0.87
Recent developments in human immunodeficiency virus-1 latency research. J Gen Virol (2013) 0.87
RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland. Dis Model Mech (2014) 0.87
Seroprevalence of pandemic 2009 (H1N1) influenza A virus among schoolchildren and their parents in Tokyo, Japan. Clin Vaccine Immunol (2011) 0.87
Diagnosis of feline leukaemia virus infection by semi-quantitative real-time polymerase chain reaction. J Feline Med Surg (2006) 0.85
A cell-based screening system for influenza A viral RNA transcription/replication inhibitors. Sci Rep (2013) 0.85
Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion. J Virol (2010) 0.85
Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection. Vet Immunol Immunopathol (2002) 0.85
Neutralization of feline immunodeficiency virus by antibodies targeting the V5 loop of Env. J Gen Virol (2009) 0.85
Epizootic canine distemper virus infection among wild mammals. Vet Microbiol (2011) 0.85
Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: absence of antigenemia following challenge. Antiviral Res (2010) 0.84
Feline immunodeficiency virus env gene evolution in experimentally infected cats. Vet Immunol Immunopathol (2009) 0.83
Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18. Vaccine (2002) 0.82
Lactoferrin expression in the horse endometrium: relevance in persisting mating-induced endometritis. Vet Immunol Immunopathol (2006) 0.81
Diverse HIV viruses are targeted by a conformationally dynamic antiviral. Nat Struct Mol Biol (2012) 0.81
Viral transcriptome analysis of feline immunodeficiency virus infected cells using second generation sequencing technology. Vet Immunol Immunopathol (2011) 0.81
Downmodulation of CD3epsilon expression in CD8alpha+beta- T cells of feline immunodeficiency virus-infected cats. J Gen Virol (2004) 0.81
Feline immunodeficiency virus integration in B-cell lymphoma identifies a candidate tumor suppressor gene on human chromosome 15q15. Cancer Res (2002) 0.81
Contribution of Sec61α to the life cycle of Ebola virus. J Infect Dis (2011) 0.81
Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements. J Virol (2004) 0.81
Mutations in the catalytic core or the C-terminus of murine leukemia virus (MLV) integrase disrupt virion infectivity and exert diverse effects on reverse transcription. Virology (2007) 0.81
sGP serves as a structural protein in Ebola virus infection. J Infect Dis (2011) 0.80
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env. J Virol (2005) 0.80
Anti-adhesive property of P-selectin glycoprotein ligand-1 (PSGL-1) due to steric hindrance effect. J Cell Biochem (2013) 0.80
Markers of feline leukaemia virus infection or exposure in cats from a region of low seroprevalence. J Feline Med Surg (2011) 0.80
Feline immunodeficiency virus (FIV) neutralization: a review. Viruses (2011) 0.80
Development of antibodies to feline IFN-gamma as tools to elucidate the cellular immune responses to FeLV. J Immunol Methods (2003) 0.80
A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus. Vaccine (2005) 0.80
Development and application of an indirect enzyme-linked immunosorbent assay for serological survey of Japanese encephalitis virus infection in dogs. J Virol Methods (2012) 0.79
A replication-incompetent virus possessing an uncleavable hemagglutinin as an influenza vaccine. Vaccine (2012) 0.79
Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus. Vaccine (2006) 0.79
Mitogen-activated protein kinase-activated kinase RSK2 plays a role in innate immune responses to influenza virus infection. J Virol (2009) 0.79
Objective assessment of brace wear times and physical activities in two patients with scoliosis. Biomed Tech (Berl) (2010) 0.79
Feline immunodeficiency virus (FIV) env recombinants are common in natural infections. Retrovirology (2014) 0.79
Demonstration of biological activity of CD40 ligand (CD154) in the domestic cat. Cytokine (2002) 0.79
Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS. Vaccine (2008) 0.79
Experimental infection of Japanese encephalitis virus in dogs. J Vet Med Sci (2011) 0.78
Establishment of a feline astrocyte-derived cell line (G355-5 cells) expressing feline CD134 and a rapid quantitative assay for T-lymphotropic feline immunodeficiency viruses. J Virol Methods (2008) 0.78
Effects of the Twin Shoe (Darco) to compensate height differences in normal gait. Gait Posture (2010) 0.78
Application of retrovirus-mediated expression cloning for receptor screening of a parasite. Anal Biochem (2009) 0.78
The murine whey acidic protein promoter directs expression to human mammary tumors after retroviral transduction. Cancer Gene Ther (2002) 0.78
Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus. Retrovirology (2012) 0.78
Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors. BMC Mol Biol (2009) 0.78
Characterization of monoclonal antibodies against canine P-selectin glycoprotein ligand-1 (PSGL-1). Vet Immunol Immunopathol (2011) 0.77
Feline infectious peritonitis virus with a large deletion in the 5'-terminal region of the spike gene retains its virulence for cats. J Gen Virol (2012) 0.77
Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats. Retrovirology (2014) 0.77
Production and characterization of monoclonal antibodies to Japanese encephalitis virus. J Vet Med Sci (2013) 0.77